Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from south Korean patients with drug-resistant tuberculosis

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 402-411

  Via, Laura E ^a   Cho, Sang Nae ^e   Hwang, Soohee ^b   Bang, Hyeeun ^d   Park, Seung Kyu ^b   Kang, Hyung Seok ^b   Jeon, Doosoo ^b,c   Min, Seon Yeong ^c   Oh, Taegwon ^c   Kim, Yeun ^d   Kim, Young Mi ^e   Rajan, Vignesh ^a   Wong, Sharon Y ^a   Shamputa, Isdore Chola ^a   Carroll, Matthew ^a   Goldfeder, Lisa ^a   Lee, Song A ^c   Holland, Steven M ^a   Eum, Seokyong ^c   Lee, Hyeyoung ^d   Barry III, Clifton E ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b National Masan Hospital   (South Korea)

^c International Tuberculosis Research Center   (South Korea)

^d Yonsei University Wonju   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; DNA 16S; ISONIAZID; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS RESISTANCE; DNA SEQUENCE; DRUG SENSITIVITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; SPUTUM CULTURE; TREATMENT OUTCOME;

AMINOGLYCOSIDES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CAPREOMYCIN; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GENES, RRNA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; REPUBLIC OF KOREA; RIBOSOMAL PROTEINS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 75649111921     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01476-09     Document Type: Article

References (30)

1. Alangaden, G. J., B. N. Kreiswirth, A. Aouad, M. Khetarpal, F. R. Igno, S. L. Moghazeh, E. K. Manavathu, and S. A. Lerner. 1998. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1295-1297.
2. Antonova, O. V., D. A. Gryadunov, S. A. Lapa, A. V. Kuz'min, E. E. Larionova, T. G. Smirnova, E. Y. Nosova, O. I. Skotnikova, L. N. Chernousova, A. M. Moroz, A. S. Zasedatelev, and V. M. Mikhailovich. 2008. Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips. Bull. Exp. Biol. Med. 145:108-113.
3. Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9:67.
4. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41:21-43.
5. Canetti, G., S. Froman, J. Grosset, P. Hauduroy, M. Langerova, H. T. Mahler, G. Meissner, D. A. Mitchison, and L. Sula. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 29:565-578.
6. Carter, A. P., W. M. Clemons, D. E. Brodersen, R. J. Morgan-Warren, B. T. Wimberly, and V. Ramakrishnan. 2000. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407:340-348.
7. Chan, E. D., and M. D. Iseman. 2008. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr. Opin. Infect. Dis. 21:587-595.
8. Donald, P. R., and P. D. van Helden. 2009. The global burden of tuberculosis-combating drug resistance in difficult times. N. Engl. J. Med. 360:2393-2395.
9. Gagneux, S., C. D. Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946.
10. Grandjean, L., and D. A. Moore. 2008. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drugresistant tuberculosis. Curr. Opin. Infect. Dis. 21:454-461.
11. Hillemann, D., S. Rusch-Gerdes, and E. Richter. 2009. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1772.
12. Hillemann, D., M. Weizenegger, T. Kubica, E. Richter, and S. Niemann. 2005. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43:3699-3703.
13. Jeon, C. Y., S. H. Hwang, J. H. Min, D. R. Prevots, L. C. Goldfeder, H. Lee, S. Y. Eum, D. S. Jeon, H. S. Kang, J. H. Kim, B. J. Kim, D. Y. Kim, S. M. Holland, S. K. Park, S. N. Cho, C. E. Barry III, and L. E. Via. 2008. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin. Infect. Dis. 46:42-49.
14. Jeon, D. S., D. H. Kim, H. S. Kang, S. H. Hwang, J. H. Min, J. H. Kim, N. M. Sung, M. W. Carroll, and S. K. Park. 2009. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 13:594-600.
15. Kim, D. H., H. J. Kim, S. K. Park, S. J. Kong, Y. S. Kim, T. H. Kim, E. K. Kim, K. M. Lee, S. S. Lee, J. S. Park, W. J. Koh, C. H. Lee, J. Y. Kim, and T. S. Shim. 2008. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 178:1075-1082.
16. Kim, S. J. 2005. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur. Respir. J. 25:564-569.
17. Kocagoz, T., E. Yilmaz, S. Ozkara, S. Kocagoz, M. Hayran, M. Sachedeva, and H. F. Chambers. 1993. Detection of Mycobacterium tuberculosis in sputum samples by polymerase chain reaction using a simplified procedure. J. Clin. Microbiol. 31:1435-1438.
18. Lacoma, A., N. Garcia-Sierra, C. Prat, J. Ruiz-Manzano, L. Haba, S. Roses, J. Maldonado, and J. Dominguez. 2008. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46:3660-3667.
19. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:3192-3197.
20. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:571-577.
21. Mokrousov, I., T. Otten, O. Manicheva, Y. Potapova, B. Vishnevsky, O. Narvskaya, and N. Rastogi. 2008. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob. Agents Chemother. 52:2937-2939.
22. Okamoto, S., A. Tamaru, C. Nakajima, K. Nishimura, Y. Tanaka, S. Tokuyama, Y. Suzuki, and K. Ochi. 2007. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol. Microbiol. 63:1096-1106.
23. Raviglione, M. C., and I. M. Smith. 2007. XDR tuberculosis- implications for global public health. N. Engl. J. Med. 356:656-659.
24. Spies, F. S., P. E. da Silva, M. O. Ribeiro, M. L. Rossetti, and A. Zaha. 2008. Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob. Agents Chemother. 52:2947-2949.
25. Springer, B., Y. G. Kidan, T. Prammananan, K. Ellrott, E. C. Bottger, and P. Sander. 2001. Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob. Agents Chemother. 45:2877-2884.
26. Sreevatsan, S., X. Pan, K. E. Stockbauer, D. L. Williams, B. N. Kreiswirth, and J. M. Musser. 1996. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob. Agents Chemother. 40:1024-1026.
27. Sun, Y. J., J. T. Luo, S. Y. Wong, and A. S. Lee. 6 June 2009, posting date. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycinresistant Mycobacterium tuberculosis isolates from Singapore. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2009.02800.
28. van Doorn, H. R., D. D. An, M. D. de Jong, N. T. Lan, D. V. Hoa, H. T. Quy, N. V. Chau, P. M. Duy, D. Q. Tho, N. T. Chinh, J. J. Farrar, and M. Caws. 2008. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int. J. Tuber. Lung Dis. 12:736-742.
29. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
30. Woods, G. L. 2000. Susceptibility testing for mycobacteria. Clin. Infect. Dis. 31:1209-1215.